A Bloomberg-backed can­cer drug sum­mit aims to thaw US-Chi­na re­la­tions

Next week, a new coali­tion will be launched in Sin­ga­pore in an ef­fort to speed can­cer drug de­vel­op­ment and en­hance re­search co­op­er­a­tion be­tween the US and Chi­na, de­spite ris­ing ten­sions.

Launched by bil­lion­aire Michael Bloomberg’s eco­nom­ic fo­rum, dubbed the Bloomberg In­ter­na­tion­al Can­cer Coali­tion, the sum­mit will bring drug ex­ecs to­geth­er from the coun­tries with the two largest can­cer pop­u­la­tions in the world. The coali­tion will aim to cre­ate new can­cer drug stan­dards and cool tem­per­a­tures that have risen dur­ing the Covid-19 pan­dem­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER